Mefenamic Acid Pellets

(Product under development)
Mefenamic Acid Pellets Mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It is typically prescribed for oral administration. Mefenamic acid is marketed in the USA as Ponstel.

Mefenamic acid decreases inflammation (swelling) and uterine contractions by a still unknown mechanism. However it is thought to be related to the inhibition of prostaglandin synthesis.

There is also evidence that supports the use of mefenamic acid for perimenstrual migraine headache prophylaxis, with treatment starting 2 days prior to the onset of flow or 1 day prior to the expected onset of the headache and continuing for the duration of menstruation.

Since hepatic metabolism plays a significant role in mefenamic acid elimination, patients with known liver deficiency may be prescribed lower doses. Kidney deficiency may also cause accumulation of the drug and its metabolites in the excretory system. Therefore patients suffering from renal conditions should not be prescribed mefenamic acid.

Available Form:
Mefenamic Acid Pellets
Mefenamic Acid Granules

Umang Pharmatech equipments used for production of Mefenamic Acid Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Mefenamic Acid Pellets
Systematic (IUPAC) Name
Mefenamic Acid Pellets
Mefenamic Acid Pellets
Chemical data
2-(2,3-dimethylphenyl)aminobenzoic acid
CAS number : 61-68-7
ATC code : M01AG01
PubChem : CID 4044
DrugBank : APRD0073
ChemSpider : 3904
UNII : 367589PJ2C
KEGG : D00151
Formula : C15H15NO2
Mol. mass : 241.285 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech